{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:18:23Z","timestamp":1777555103441,"version":"3.51.4"},"reference-count":11,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>\n                      <jats:underline>Abstract: Background:<\/jats:underline>\n                    <\/jats:title>\n                    <jats:p>Supplemental patch testing is an adjunct to standard patch test screening series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:underline>Objective:<\/jats:underline>\n                    <\/jats:title>\n                    <jats:p>To determine the demographics, characteristics, frequency, relevance, and interpretation of patch test reactions for supplemental patch testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:underline>Methods:<\/jats:underline>\n                    <\/jats:title>\n                    <jats:p>Retrospective study of patients tested 2017\u20132020 with North American Contact Dermatitis Group (NACDG) and supplemental screening series (Supplemental Series A [SSA], Supplemental Series B [SSB]). Demographics, characteristics, reaction strengths, relevance, and final interpretation were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:underline>Results:<\/jats:underline>\n                    <\/jats:title>\n                    <jats:p>Cohort included 791 patients; 73.5% female, 68.6% age &gt;40 years. 74.1% were White, 15.2% Black, 5.7% Asian, and 1.5% Hispanic. The most common Dermatitis sites were scattered\/generalized (27.2%), face (24.0%), and hands (23.5%). For 2017\u20132018 and 2019\u20132020, respectively, 82% (318\/388) and 78.4% (316\/403) had \u22651 \u201callergic\u201d reaction. In addition, 13.5% (52\/385) and 11.7% (47\/403) had SSA reactions, and 38.1% (115\/302) and 31.5% (101\/321) had SSB reactions. In the 87 (2017\u20132018) and 99 (2019\u20132020) patients with negative NACDG testing, 17 (19.5%) and 12 (12.1%) had supplemental reactions. Of the 34 supplemental allergens with reaction frequency \u22651%, 58.8% (20\/34) are not part of the American Contact Dermatitis Society 90 (2020) or NACDG 2021\u20132022 screening series. The highest frequency allergens from this group were dodecyl and octyl gallate, cinnamic alcohol, phenyl salicylate, hexahydro-1,3,5-tris-(2-hydroxyethyl) triazine, and abitol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:underline>Conclusions:<\/jats:underline>\n                    <\/jats:title>\n                    <jats:p>Supplemental patch testing identifies additional relevant allergens in patients with suspected allergic contact Dermatitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/derm.2023.0310","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T11:40:01Z","timestamp":1706528401000},"page":"366-372","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-0014","authenticated-orcid":false,"given":"Amber Reck","family":"Atwater","sequence":"first","affiliation":[{"name":"From the Departments of,  Dermatology, Duke University Medical Center, Durham, North Carolina, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beiyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabina","family":"Walsh","sequence":"additional","affiliation":[{"name":"From the Departments of,  Dermatology, Duke University Medical Center, Durham, North Carolina, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Bembry","sequence":"additional","affiliation":[{"name":"From the Departments of,  Dermatology, Duke University Medical Center, Durham, North Carolina, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan Maxwell","family":"Ward","sequence":"additional","affiliation":[{"name":"From the Departments of,  Dermatology, Duke University Medical Center, Durham, North Carolina, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia L.","family":"Green","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000674"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4314"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.11.033"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2022.29017.jdk"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000729"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000621"},{"key":"e_1_3_1_10_2","article-title":"President, North American Contact Dermatitis Group","author":"DeKoven JG.","year":"2023","unstructured":"DeKoven JG. President, North American Contact Dermatitis Group. Personal Communication, 2023.","journal-title":"Personal Communication"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.3045"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13690"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/derm.2023.0310","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2023.0310","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2023.0310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:08:41Z","timestamp":1777399721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/derm.2023.0310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,1]]}},"alternative-id":["10.1089\/derm.2023.0310"],"URL":"https:\/\/doi.org\/10.1089\/derm.2023.0310","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}